FDA ap­proves GSK's MMR vac­cine, the first new green light in more than half a cen­tu­ry

GSK is bring­ing one of its wide­ly-li­censed vac­cines to the US, giv­ing pe­di­a­tri­cians a new op­tion for a com­mon child­hood shot for the first time in more than 50 years.

The FDA ap­proved GSK’s measles, mumps and rubel­la vac­cine for in­di­vid­u­als 12 months and old­er, the com­pa­ny an­nounced Mon­day morn­ing. Brand­ed as Pri­or­ix, the shot had al­ready been li­censed in more than 100 oth­er coun­tries be­fore com­ing to the US.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.


Alexandria Real Estate Equities

San Diego, CA, USA